VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies

Nature Medicine

Volumn 8, Issue 8, 2002, Pages 775-777

  Eriksson, Ulf ^a   Alitalo, Kari ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL MODEL; ATHEROSCLEROSIS; BLOOD VESSEL; BONE MARROW; DIABETES MELLITUS; GENE TARGETING; HEMATOPOIETIC STEM CELL; INFLAMMATION; METASTASIS; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL MOBILIZATION; STROKE; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BONE MARROW CELLS; ENDOTHELIAL GROWTH FACTORS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOKINES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ADENOVIRIDAE; ANIMALIA;

EID: 0036344816     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0802-775     Document Type: Short Survey

References (18)

1. Angiogenesis in cancer and other diseases
2. The biology of vascular endothelial growth factor
3. Clinical applications of angiogenic growth factors and their inhibitors
4. Angiogenesis therapy: Amidst the hype, the neglected potential for serious side effects
5. Revascularization of ischemic tissues by PIGF treatment and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt-1 antibody
6. + stem cells from bone marrow microenviroment
7. VEGF regulates hematopoietic stem cell survival by an internal autocrine loop mechanism
8. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors
9. Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect
10. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
11. VEGF receptor signal transduction
12. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
13. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
14. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis In mice
15. Developmental control of blood cell migration by the Drosophila VEGF pathway
16. KDR receptor: A key marker defining hematopoietic stem cells
17. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic
18. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis